Literature DB >> 2076741

Development of an ELISA to study the polymorphism of dextromethorphan oxidation in a French population.

J P Frèche1, S Dragacci, A M Petit, J P Siest, M M Galteau, G Siest.   

Abstract

Simple, sensitive and selective enzyme immunoassays (ELISA) for monitoring urinary dextromethorphan and its major metabolite, dextrorphan, were developed. Dextromethorphan and dextrorphan hemisuccinates were linked to bovine serum albumin and specific antisera against each immunogen were raised in rabbits. The sensitivity of the ELISA was high (limit of detection 740 and 600 pg.ml-1 for dextromethorphan and dextrorphan, respectively). Intra- and interassay variation was less than 10%, and cross-reactivity between the two compounds was less than 1%. The ELISA was employed to phenotype 216 French subjects. The frequency of poor metabolizers was 5.1%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076741     DOI: 10.1007/BF00280940

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Direct determination of dextromethorphan and its three metabolites in urine by high-performance liquid chromatography using a precolumn switching system for sample clean-up.

Authors:  N Motassim; D Decolin; T Le Dinh; A Nicolas; G Siest
Journal:  J Chromatogr       Date:  1987-11-27

2.  Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism.

Authors:  A Küpfer; B Schmid; R Preisig; G Pfaff
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

3.  Phenotyping polymorphic drug metabolism in the French Caucasian population.

Authors:  E Jacqz; H Dulac; H Mathieu
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Inherited defects of hepatic drug metabolism.

Authors:  A Küpfer; R Preisig
Journal:  Semin Liver Dis       Date:  1983-11       Impact factor: 6.115

Review 5.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

6.  Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.

Authors:  L M Distlerath; P E Reilly; M V Martin; G G Davis; G R Wilkinson; F P Guengerich
Journal:  J Biol Chem       Date:  1985-07-25       Impact factor: 5.157

7.  Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.

Authors:  B Schmid; J Bircher; R Preisig; A Küpfer
Journal:  Clin Pharmacol Ther       Date:  1985-12       Impact factor: 6.875

8.  Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase high-performance liquid chromatography.

Authors:  Y H Park; M P Kullberg; O N Hinsvark
Journal:  J Pharm Sci       Date:  1984-01       Impact factor: 3.534

9.  Dextromethorphan: radioimmunoassay and pharmacokinetics in the dog.

Authors:  R Dixon; J J Carbone; E Mohacsi; C Perry
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-11

10.  Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

Authors:  F J Gonzalez; R C Skoda; S Kimura; M Umeno; U M Zanger; D W Nebert; H V Gelboin; J P Hardwick; U A Meyer
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.